MedTrace Logo

The Role of Quantitative CT and Radiomic Biomarkers for Precision Medicine in Pulmonary Fibrosis

NCT06323876 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 160

Last updated 2024-08-16

No results posted yet for this study

Summary

This observational study involves obtaining 2 chest CT scans; a historical baseline CT within ±1 year of enrollment into PRECISIONS, and a follow-up CT (either historical or prospective) 12 months ± 180 days after the baseline CT. Many IPF patients will have a CT scan every 12 months for disease monitoring and cancer screening. Participants will have the option to share historical CTs only or they can choose to have a research CT done for the follow-up scan, if a scan for clinical purposes is not available.

Conditions

Interventions

DIAGNOSTIC_TEST

HRCT

High resolution computed tomography (HRCT) scan is a medical imaging technique used to obtain detailed internal images of the body. HRCT images will be obtained at 0 and 12 months.

DIAGNOSTIC_TEST

Blood Draw

During blood draw, someone uses a needle to take blood from a vein, usually in your arm.

Sponsors & Collaborators

  • National Heart, Lung, and Blood Institute (NHLBI)

    collaborator NIH

  • University of Virginia

    lead OTHER

Principal Investigators

  • Noth Imre, MD · Division of Pulmonary and Critical Care

  • John Kim · Division of Pulmonary and Critical Care

Eligibility

Min Age
40 Years
Max Age
101 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-06-20
Primary Completion
2028-05-31
Completion
2029-05-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06323876 on ClinicalTrials.gov